Jul 30, 2021

New research: How women’s hormone therapies could help reduce the risk of dementia

Senior woman at beach

A new study by the University of Arizona Health Sciences has found that women using hormone therapies were up to 58% less likely to develop neurodegenerative diseases, such as dementia.

The degree of risk varied depending on the type and application method of hormone therapy and how long the therapy was used.

“What is important about this study is that it advances the use of precision hormone therapies in the prevention of neurodegenerative disease, including Alzheimer’s,” said Roberta Diaz Brinton PhD, Director of the University of Arizona Center for Innovation in Brain Science and the senior author of the paper. 

Hormone therapy is used to treat the symptoms of menopause, which can include hot flashes, night sweats, insomnia, weight gain and depression. 

In the study, the researchers looked at the insurance claims of nearly 400,000 women aged 45 and older who were in menopause.

The researchers focused on the effects of hormone therapy medications on neurodegenerative diseases, and looked at the impacts of the type of hormone therapy, the route of administration (oral vs through the skin) and how long the therapy was taken.

Hormone therapies taken orally resulted in a reduced risk for combined neurodegenerative diseases.

Hormone therapies administered through the skin reduced the risk of developing dementia. 

The risk of developing neurodegenerative disease overall was reduced the most in patients 65 years or older.

Long-term therapy (longer than one year) had a greater protective effect on developing Alzheimer’s, Parkinson’s disease and dementia compared to short-term therapy (less than one year).

A press release from the university said the findings could lead to the development of medicines that could prevent neurodegenerative diseases.

“The key is that hormone therapy is not a treatment, but it’s keeping the brain and this whole system functioning, leading to prevention. It’s not reversing disease; it’s preventing disease by keeping the brain healthy.”

Given the global problems associated with ageing populations, neurodegenerative diseases associated with ageing are major public health issues.

Currently, there is no known cure for dementia, which affects nearly 500,000 people in Australia and 50 million worldwide.

Leave a Reply

Your email address will not be published. Required fields are marked *

  1. Any indication that they wouldn’t suffer a Stroke, cos I took HRT for 10years and had a stroke! But I don’t have dementia and I’m 82.

Advertisement
Advertisement
Advertisement

When is it OK to take a rapid antigen test for COVID rather than lining up for a PCR swab?

Now we have access to PCR tests (known as RT-PCR, or reverse transcription-polymerase chain reaction, tests) and rapid antigen tests to detect SARS-CoV-2, the virus that causes COVID. So which test should you use? And what’s the difference? Read More

For the love of grandparents

Dementia is the second leading cause of deaths in Australia (ABS, 2016). In a report prepared for Alzheimer’s Australia, it was projected that over 6.4 million Australia people would be diagnosed with dementia over the next 40 years. The cost projected alongside this trend is estimated to be more than $1 trillion (Economic cost of... Read More

Do You Know How Much it Costs to Care For Someone with Dementia?

Receiving a dementia diagnosis can be a challenging experience for a person and their loved ones. They say that an early diagnosis is ideal, because it allows their family and the person with the condition to prepare for the future. This usually means getting their affairs in order and making choices that they may not... Read More
Advertisement